MARKET

CNMD

CNMD

CONMED
NYSE

Real-time Quotes | Nasdaq Last Sale

73.34
-2.19
-2.90%
After Hours: 73.42 +0.08 +0.11% 16:09 09/23 EDT
OPEN
75.73
PREV CLOSE
75.53
HIGH
75.73
LOW
73.34
VOLUME
176.07K
TURNOVER
--
52 WEEK HIGH
116.81
52 WEEK LOW
37.66
MARKET CAP
2.10B
P/E (TTM)
-2676.6423
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Hedge Funds Have Never Been More Bullish On CONMED Corporation (CNMD)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend
Insider Monkey · 09/15 16:01
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
CONMED Corporation (NYSE:CNMD), is not the largest company out there, but it saw a significant share price rise of...
Simply Wall St. · 09/13 15:27
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference at 3:30 p.m
Business Wire · 09/03 21:05
CONMED declares $0.20 dividend
CONMED (CNMD) declares $0.20/share quarterly dividend, in line with previous.Forward yield 0.93%Payable Oct. 5; for shareholders of record Sept. 15; ex-div Sept. 14.See CNMD Dividend Scorecard, Yield Chart, & Dividend
Seekingalpha · 08/13 20:22
CONMED Corporation 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 07/30 04:00
CONMED EPS beats by $0.88, beats on revenue
CONMED (NYSE:CNMD): Q2 Non-GAAP EPS of -$0.07 beats by $0.88; GAAP EPS of -$0.96 beats by $0.37. Revenue of $157.79M (-33.8% Y/Y) beats by $31.2M. Press Re
seekingalpha · 07/30 01:07
Conmed: Q2 Earnings Insights
Shares of Conmed (NYSE:CNMD) moved higher by 4.42% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 112.50% over the past year to ($0.07), which beat the estimate of ($0.95).Revenue of $157,785,000 de
Benzinga · 07/29 20:59
CONMED Corporation Announces Second Quarter 2020 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2020.
Business Wire · 07/29 20:05
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CNMD. Analyze the recent business situations of CONMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CNMD stock price target is 95.50 with a high estimate of 100.00 and a low estimate of 92.00.
EPS
Institutional Holdings
Institutions: 250
Institutional Holdings: 30.39M
% Owned: 106.37%
Shares Outstanding: 28.57M
TypeInstitutionsShares
Increased
163
-431.64K
New
31
883.38K
Decreased
0
0
Sold Out
27
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.42%
Healthcare Equipment & Supplies
-1.47%
Key Executives
Chairman/President/Chief Executive Officer/Director
Curt Hartman
Chief Financial Officer/Executive Vice President/IR Contact Officer
Todd Garner
Corporate Executive
Patrick Beyer
Executive Vice President/General Counsel/Secretary
Daniel Jonas
Executive Vice President/Director of Human Resources/Secretary
Heather Cohen
Executive Vice President
Wilfredo Ruiz-Caban
Executive Vice President
Peter Shagory
Vice President/General Manager
Nathan Folkert
Vice President/General Manager
John Kennedy
Vice President/General Manager
Stanley Peters
Vice President/Controller
Terence Berge
Vice President/Treasurer
Johonna Pelletier
General Counsel/Assistant Secretary
Sarah Oliker
Lead Director/Independent Director
Martha Aronson
General Counsel/Assistant Secretary
SARAH OLIKER
Director
Mark Tryniski
Independent Director
David Bronson
Independent Director
Brian Concannon
Independent Director
Laverne Council
Independent Director
Charles Farkas
Independent Director
Jerome Lande
Independent Director
Barbara Schwarzentraub
Independent Director
John Workman
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
08/13/2020
Dividend USD 0.2
09/14/2020
05/21/2020
Dividend USD 0.2
06/12/2020
02/25/2020
Dividend USD 0.2
03/13/2020
11/21/2019
Dividend USD 0.2
12/12/2019
08/01/2019
Dividend USD 0.2
09/12/2019
05/22/2019
Dividend USD 0.2
06/13/2019
02/26/2019
Dividend USD 0.2
03/14/2019
11/08/2018
Dividend USD 0.2
12/13/2018
08/14/2018
Dividend USD 0.2
09/13/2018
05/24/2018
Dividend USD 0.2
06/14/2018
02/28/2018
Dividend USD 0.2
03/14/2018
11/27/2017
Dividend USD 0.2
12/14/2017
08/29/2017
Dividend USD 0.2
09/14/2017
05/24/2017
Dividend USD 0.2
06/13/2017
02/28/2017
Dividend USD 0.2
03/13/2017
11/21/2016
Dividend USD 0.2
12/13/2016
08/25/2016
Dividend USD 0.2
09/13/2016
05/25/2016
Dividend USD 0.2
06/13/2016
02/23/2016
Dividend USD 0.2
03/11/2016
11/16/2015
Dividend USD 0.2
12/11/2015
08/24/2015
Dividend USD 0.2
09/11/2015
05/28/2015
Dividend USD 0.2
06/11/2015
02/24/2015
Dividend USD 0.2
03/12/2015
11/17/2014
Dividend USD 0.2
12/11/2014
08/22/2014
Dividend USD 0.2
09/11/2014
05/22/2014
Dividend USD 0.2
06/12/2014
02/25/2014
Dividend USD 0.2
03/13/2014
10/28/2013
Dividend USD 0.2
12/12/2013
08/27/2013
Dividend USD 0.15
09/12/2013
05/23/2013
Dividend USD 0.15
06/13/2013
02/27/2013
Dividend USD 0.15
03/13/2013
12/03/2012
Dividend USD 0.15
12/13/2012
08/29/2012
Dividend USD 0.15
09/12/2012
05/21/2012
Dividend USD 0.15
06/13/2012
02/29/2012
Dividend USD 0.15
03/13/2012
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CNMD
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company's product lines consist of orthopedic surgery and general surgery.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Conmed Corp stock information, including NYSE:CNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CNMD stock methods without spending real money on the virtual paper trading platform.